GAITHERSBURG, Md., US, November 7, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...
Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce ...
Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
News-Medical.Net on MSN
Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment
Ianalumab targets the B-cell activating factor receptor (BAFR) and ibrutinib belongs to a class of therapeutics called Bruton ...
Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, ...
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the ...
Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...
Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...
Prime Minister Narendra Modi gifted three path-breaking innovations, including CART-T Cell Therapy, India''s first indigemous cancer cell therapy developed by Indian Innovators with the support of the ...
The poster, titled Translational Insights from a First-in-Human Study of an Oral CBL-B Inhibitor in Advanced Solid Tumors, expands upon data presented at the recent European Society for Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback